Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nucleic Acids Res ; 9(15): 3863-72, 1981 Aug 11.
Article in English | MEDLINE | ID: mdl-7279674

ABSTRACT

Irradiation of aqueous solutions of native calf thymus DNA with x-rays produced functional groups that reacted with sodium borohydride. The DNA was labeled with tritium from NaB3H4 to the extent of 2.0 x 10(-10) atom/dalton/rad. The presence of cysteamine or other radical scavengers, or saturation of the solution with nitrogen during irradiation decreased the labeling. After mild acid hydrolysis, the major tritium-containing moiety was identical with 2,3-dihydroxy-2-methylpropanoic acid in all chromatographic systems tested. The suggested mechanism of labeling involved reduction by borohydride of the potential aldehyde at carbon 6 of thymine glycol residues present in the irradiated DNA.


Subject(s)
DNA/radiation effects , Animals , Borohydrides , Cattle , Dose-Response Relationship, Radiation , Kinetics , Thymus Gland , Tritium
2.
Res Commun Chem Pathol Pharmacol ; 29(2): 309-15, 1980 Aug.
Article in English | MEDLINE | ID: mdl-7414051

ABSTRACT

Pretreatment for four days with coenzyme Q10 (CoQ10) significantly lowered the acute toxicity in female C3H/HeNCrlBR mice given moderately lethal (15.0 and 20.0 mg/kg) i.p. doses of adriamycin as well as in male ICR/Hla mice given 12.5 mg/kg i.p. adriamycin. In both strains of mice, CoQ10 pretreatment did not protect the mice at higher i.p. adriamycin dose levels. When adriamycin was administered by the clinically-used i.v. route, CoQ10 pretreatment did not reduce acute toxicity at moderately lethal doses in either strain. At higher i.v. adriamycin dose levels, CoQ10 pretreatment significantly enhanced acute toxicity. CoQ10 pretreatment did not alter the antitumor effectiveness of adriamycin (i.p. or i.v.) against the Dunn osteosarcoma.


Subject(s)
Doxorubicin/toxicity , Ubiquinone/pharmacology , Animals , Body Weight/drug effects , Doxorubicin/therapeutic use , Female , Lung Neoplasms/drug therapy , Male , Mice , Mice, Inbred C3H , Sarcoma, Experimental/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...